Fisher & Paykel Healthcare Corporation Limited announced today that it intends to release on Wednesday, 29 November 2023 its financial results for the six months ended 30 September 2023. The release will be issued before 9:00am NZDT, 7:00am AEDT (3:00pm USEST, Tuesday, 28 November).
 
Fisher & Paykel Healthcare will host a conference call on Wednesday, 29 November 2023 to discuss the half year result. The conference call is scheduled to begin at 10:00am NZDT, 8:00am AEDT (4:00pm USEST, Tuesday 28 November) and will be simultaneously broadcast online.
 
Webcast details
 
To listen to the webcast, access the company’s website at www.fphcare.com/investor. An online archive of the event will be available approximately two hours after the webcast and will remain on the site for two weeks.
 
Conference call details (please note the new instructions for investors and analysts)
 
To listen and participate in the conference call via phone, please register via ‘GlobalMeet’ by clicking this link. Once registered, click ‘Call Me’ and you will receive a phone call connecting you through to the conference line.
 

About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in more than 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.

 

Media & Investor Contacts:

Hayden Brown Head of Capital Markets & Investor Relations hayden.brown@fphcare.co.nz +64 (0) 27 807 8073   Dan Adolph Senior Communications and Investor Relations Manager daniel.adolph@fphcare.co.nz +64 (0) 22 511 4050

Authorised by Raelene Leonard, General Counsel and Company Secretary.